Abbott's Xience V drug-eluting stent (DES) appears to be safer than Cypher, Johnson & Johnson's older DES, and may be associated with lower rates of stent thrombosis over the long term. Results from the LESSON I trial, presented yesterday at the annual meeting of the European ...
Please Login to read the full article.
